首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pathophysiology of haemostasis and thrombosis

缩写:

ISSN:1424-8832

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引315
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Edwin Ten Boekel,Piet Bartels Edwin Ten Boekel
Abnormally short activated partial thromboplastin times (APTTs) are associated with an increased risk of thrombotic disorders. We have examined the status of coagulation activity in subjects with short APTTs. In addition, the presence of th...
Isabelle Mahé,Ludovic Drouet,Oliver Chassany et al. Isabelle Mahé et al.
Monitoring of anti-Xa activity (aXa) levels is not routinely required in patients receiving enoxaparine at prophylactic dosages, since aXa is supposed to stay below the manufacturer's recommended range in patients treated for venous thrombo...
M J Kovacs,D A Anderson,P S Wells M J Kovacs
Venous thromboembolism is a common medical problem. Recently, the emphasis has been on a switch to outpatient low molecular weight heparin therapy. Previous warfarin nomograms have been developed only for inpatients. We prospectively assess...
A Trifiletti,A Lasco,R Scamardi et al. A Trifiletti et al.
First-degree relatives of type 2 diabetic patients with or without a family history of hypertension are at increased risk for cardiovascular diseases. The aim of this study was to verify some possible hemostatic alterations in first-degree ...
F Jung,S G Spitzer,G Pindur F Jung
The aim of the present study was to evaluate the effects of ionic (ioxaglate) and non-ionic (iopromide) contrast media on haemostatic parameters ex vivo. In 40 patients undergoing coronary angiography, platelet function (platelet reactivity...
M Vacas,M J Aguirrebeitia,P J Lafuente et al. M Vacas et al.
Prothrombin time (PT) is the control test for oral anticoagulant therapy as well as the screening test for defects of the extrinsic pathway of coagulation. Its responsiveness to decreased extrinsic clotting factors depends on the source and...
J F van Der Heijden,M G H Remkes,H R Büller et al. J F van Der Heijden et al.
To prevent venous and arterial thrombosis vitamin K antagonists (VKA) are the treatment of choice for many indications. It is important to balance the benefits and the potential hazards of this treatment. An effective way to prevent unneces...
Majdi M Abdel-Raheem,Anil Potti,Sherine Tadros et al. Majdi M Abdel-Raheem et al.
Background: Low-molecular-weight heparins (LMWHs) are being preferred to unfractionated heparin (UFH) because of their superior convenience and a comparable or slightly better toxicity profile. Whether LMWH has an inhibit...
Amiram Eldor,Joseph Schwartz Amiram Eldor
The efficacy of oral anticoagulants (OAC) in reducing the incidence of stroke in elderly patients with atrial fibrillation (AF) has been well documented. The intensity of OAC therapy and deviations in the prothrombin time (PT) are the stron...
Marco Ruggiero,Michele Melli,Bruna Parma et al. Marco Ruggiero et al.
Endogenous N-sulfated glycosaminoglycans (GAGs) comigrating with standard heparin and sensitive to nitrous acid treatment were isolated from plasma of healthy donors. The amount of these compounds was 7-10 microg/ml, and activated partial t...